Melanocortin Subtype 2 Receptor (MC2R) Antagonists and Their Uses

MA52806B1Active Publication Date: 2026-08-31CRINETICS PHARMACEUTICALS INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA52806
Authority / Receiving Office: MA · MA
Patent Type: Patents
Current Assignee / Owner
Priority Date: 2019-06-05
Filing Date: 2019-06-05
Publication Date: 2026-08-31
Estimated Expiration: 2039-06-05

Application Information

Patent Timeline

05 Jun 2019

Priority

05 Jun 2019

Application

MA52806

31 Aug 2026

Publication

MA52806B1

IPC: A61K31/495; A61K31/496; A61P5/00; C07D241/04; C07D401/10; C07D401/14; C07D405/14; C07D409/14; C07D413/14; C07D453/02

CPC: C07D401/10; C07D401/14; C07D405/14; C07D409/14; C07D413/14; C07D453/02; C07D241/04; A61P5/00

Inventors: ZHAO Jian; ZHU Yunfei

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The invention relates to compounds that are modulators of the melanocortin receptor subtype 2 (MC2R), methods of manufacturing such compounds, pharmaceutical compositions and drugs comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases or disorders that may be alleviated by modulating MC2R activity.

Need to check novelty before this filing date? Find Prior Art

Explore free tools for quick IP tasks

Patent Information

Abstract